Chicago Partners Investment Group LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 221 filers reported holding IMMUNOGEN INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Chicago Partners Investment Group LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2023$102,947
-3.7%
25,482
+13.7%
0.01%
-14.3%
Q4 2022$106,877
-17.8%
22,406
-1.7%
0.01%
-22.2%
Q3 2022$130,000
+32.7%
22,794
+10.1%
0.01%
+28.6%
Q2 2022$98,000
+34.2%
20,695
-0.8%
0.01%
+16.7%
Q1 2022$73,000
-41.1%
20,856
-6.9%
0.01%
-33.3%
Q4 2021$124,000
-27.9%
22,394
-26.4%
0.01%
-25.0%
Q3 2021$172,000
-50.0%
30,417
-50.8%
0.01%
-7.7%
Q2 2021$344,000
+72.9%
61,874
+152.8%
0.01%
-18.8%
Q1 2021$199,00024,4770.02%
Other shareholders
IMMUNOGEN INC shareholders Q3 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders